Bremer Trust National Association decreased its stake in Cvs Health Corp (CVS) by 12.95% based on its latest 2016Q4 regulatory filing with the SEC. Bremer Trust National Association sold 4,193 shares as the company’s stock declined 4.23% while stock markets rallied. The institutional investor held 28,176 shares of the medical and nursing services company at the end of 2016Q4, valued at $2.22M, down from 32,369 at the end of the previous reported quarter. Bremer Trust National Association who had been investing in Cvs Health Corp for a number of months, seems to be less bullish one the $79.21B market cap company. The stock increased 0.80% or $0.62 on September 1, reaching $77.92. About shares traded. CVS Health Corp (NYSE:CVS) has declined 24.40% since September 3, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.
Sensato Investors Llc increased its stake in Taiwan Semiconductor Mfg Ltd (TSM) by 71.2% based on its latest 2016Q4 regulatory filing with the SEC. Sensato Investors Llc bought 146,700 shares as the company’s stock rose 8.84% with the market. The institutional investor held 352,727 shares of the semiconductors company at the end of 2016Q4, valued at $10.14 million, up from 206,027 at the end of the previous reported quarter. Sensato Investors Llc who had been investing in Taiwan Semiconductor Mfg Ltd for a number of months, seems to be bullish on the $186.02B market cap company. The stock increased 0.68% or $0.25 on September 1, reaching $37.22. About shares traded. Taiwan Semiconductor Mfg. Co. Ltd. (ADR) (NYSE:TSM) has risen 51.40% since September 3, 2016 and is uptrending. It has outperformed by 34.70% the S&P500.
Sensato Investors Llc, which manages about $3.62 billion and $581.13 million US Long portfolio, decreased its stake in Icici Bk Ltd (NYSE:IBN) by 2.05M shares to 39,200 shares, valued at $294,000 in 2016Q4, according to the filing. It also reduced its holding in Kongzhong Corp (NASDAQ:KZ) by 154,609 shares in the quarter, leaving it with 462,882 shares, and cut its stake in Applied Matls Inc (NASDAQ:AMAT).
Among 5 analysts covering Taiwan Semiconductor Manufacturing (NYSE:TSM), 1 have Buy rating, 0 Sell and 4 Hold. Therefore 20% are positive. Taiwan Semiconductor Manufacturing had 9 analyst reports since August 24, 2015 according to SRatingsIntel. The rating was upgraded by Pacific Crest to “Sector Weight” on Friday, October 14. The stock of Taiwan Semiconductor Mfg. Co. Ltd. (ADR) (NYSE:TSM) earned “Outperform” rating by Credit Suisse on Friday, December 11. The stock of Taiwan Semiconductor Mfg. Co. Ltd. (ADR) (NYSE:TSM) has “Hold” rating given on Thursday, October 13 by HSBC. The rating was downgraded by HSBC to “Hold” on Wednesday, June 21. The company was upgraded on Tuesday, October 4 by Susquehanna. Goldman Sachs downgraded the shares of TSM in report on Tuesday, June 28 to “Neutral” rating.
Among 23 analysts covering CVS Health (NYSE:CVS), 13 have Buy rating, 0 Sell and 10 Hold. Therefore 57% are positive. CVS Health had 38 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of CVS Health Corp (NYSE:CVS) has “Overweight” rating given on Friday, December 18 by Barclays Capital. The stock of CVS Health Corp (NYSE:CVS) has “Buy” rating given on Thursday, October 6 by UBS. The stock of CVS Health Corp (NYSE:CVS) earned “Overweight” rating by JP Morgan on Monday, November 2. Barclays Capital reinitiated the shares of CVS in report on Thursday, March 10 with “Overweight” rating. The stock has “Buy” rating by Evercore on Wednesday, August 19. The rating was maintained by Jefferies with “Hold” on Friday, June 9. Citigroup maintained the shares of CVS in report on Monday, May 9 with “Neutral” rating. The stock of CVS Health Corp (NYSE:CVS) has “Neutral” rating given on Thursday, February 2 by Robert W. Baird. RBC Capital Markets maintained the shares of CVS in report on Wednesday, August 5 with “Outperform” rating. Atlantic Securities downgraded the shares of CVS in report on Monday, February 6 to “Neutral” rating.
More notable recent CVS Health Corp (NYSE:CVS) news were published by: Bna.com which released: “CVS Hit With Generic Drug Pricing Class Action” on August 09, 2017, also Seekingalpha.com with their article: “Is It Time To Buy CVS?” published on August 15, 2017, Reuters.com published: “CVS Health’s dull third-quarter forecast overshadows profit beat” on August 08, 2017. More interesting news about CVS Health Corp (NYSE:CVS) were released by: Bloomberg.com and their article: “CVS Health Is Sued Over ‘Clawbacks’ of Prescription Drug Co-Pays” published on August 08, 2017 as well as Seekingalpha.com‘s news article titled: “CVS: Should You Ignore Negative Sentiment?” with publication date: August 30, 2017.
Investors sentiment decreased to 0.74 in 2016 Q4. Its down 0.24, from 0.98 in 2016Q3. It dived, as 135 investors sold CVS shares while 627 reduced holdings. 127 funds opened positions while 440 raised stakes. 830.51 million shares or 0.72% less from 836.58 million shares in 2016Q3 were reported. Jacobs Levy Equity Management has invested 0.82% in CVS Health Corp (NYSE:CVS). Farmers Retail Bank has 2,651 shares. Hanson And Doremus Investment Mngmt reported 200 shares. Cypress Asset Management Tx reported 30,620 shares or 0.46% of all its holdings. North Carolina-based Kdi Prtn Ltd Liability has invested 4.15% in CVS Health Corp (NYSE:CVS). Banque Pictet Cie Sa reported 314,460 shares. Legal & General Gp Public Ltd Co reported 5.04 million shares. Olstein Capital Limited Partnership holds 1.42% or 140,000 shares in its portfolio. 1,410 were accumulated by Gemmer Asset Mgmt Ltd. Novare Capital Management Ltd Liability Com reported 1.84% in CVS Health Corp (NYSE:CVS). Comml Bank Of Nova Scotia Trust holds 0.75% or 82,585 shares in its portfolio. Tiaa Cref Investment Management Lc invested in 5.67 million shares or 0.33% of the stock. Boys Arnold reported 79,340 shares stake. E&G Advisors LP holds 0.37% or 7,891 shares in its portfolio. Clal Insurance Enterp reported 20,000 shares.
Since March 10, 2017, it had 0 buys, and 5 selling transactions for $29.65 million activity. Sussman Andrew sold $1.13M worth of stock or 14,104 shares. Denton David M also sold $18.44M worth of CVS Health Corp (NYSE:CVS) shares. On Friday, March 17 the insider Boratto Eva C sold $479,908.